Here is a link to a podcast summarizing some of the presentations from the ASCO Breast Cancer Symposium.
This is only a partial summary.
http://www.cancer.net/patient/Library/Podcasts/2009_Breast_Cancer_Symposium .mp3
Additionally, below you will find a couple of my favorite links. Many of you may already have these, but perhaps others may find these interesting.
www.medicalnewstoday.com
"Science Translational Medicine" is a new journal intended to help spread basic research advances into clinics and hospitals". http://stm.sciencemag.org/ This publication looks quite interesting. It has many varied topics but one can do a specific search for breast cancer related topics. Translational medicine is the hot button. I believe that gpawelski will find some interesting information in this issue on assays. Happy reading!
Already a member? Sign in
Welcome to Inspire!
What - Inspire is a place where you can connect with people who share your health concerns and find information and advice in groups sponsored by organizations you know and trust.
Why - As a member you can use Inspire to let friends and family know how you're doing, contact others who share your health concerns, receive personalized updates and information about participating in surveys and clinical trials, and more.
How - Joining Inspire is completely free and usually takes less than a minute. Join now!
ASCO Breast Cancer Symposium Podcast and resources
- By Saraj
- Posted October 14, 2009 at 10:45 pm · 1 reply
- In Research findings
- Shared with the public
Explore topics in this discussion:
1 reply
- By gpawelski
- Posted October 18, 2009 at 11:55 am
- Report post
Thanks Saraj
I do agree that strategic alliances are the way of the future where acedeme and industry work together toward common goals that benefit patients.
The whole concept of proper genetic markers is not to put patients in the position of having to receive toxic cancer drugs if they're not going to do any good. However, genomics is far too limited in scope to encompass the vagaries and complexities of human cancer biology when it comes to drug selection.
Efforts to administer targeted therapies in randomly selected patients often result in low response rates at significant toxicity and cost. While researchers continue to develop molecular probes to select candidates, the cell culture analysis platform serves as a functional profile capable of examining the nuances of cellular response to drugs. To exploit the full potential of targeted anticancer therapies, physicians will need laboratory tests that match patients to specific drugs.
Cell culture assays are able to accurately predict how an individual patient's cancer cells will respond to an array of drug combinations. It is able to quantify synergistic drug combinations and individually tailor treatment.
Add to the discussion